MetaADEDB 2.0 @ LMMD
temsirolimus
(CBPNZQVSJQDFBE-FUXHJELOSA-N)
Structure
SMILES
CO[C@@H]1C[C@@H](CC[C@H]1OC(=O)C(CO)(CO)C)C[C@H]([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](OC)/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C1)C)/C)O)OC)C)C)/C)C
Type(s)
Approved
ATC code(s)
L01XE09
Molecular Formula:
C56H87NO16
Molecular Weight:
1030.290
Log P:
5.6603
Hydrogen Bond Acceptor:
17
Hydrogen Bond Donor:
4
TPSA:
241.96
CAS Number(s):
162635-04-3
Synonym(s)
1.
temsirolimus
2.
CCI 779
3.
CCI-779
4.
Torisel
5.
rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate)
External Link(s)
MeSHC401859
PubChem Compound6918289
23724530
BindingDB50343413
ChEBI79699
CHEMBLCHEMBL1201182
DrugBankDB06287
DrugCentral4161
IUPHAR/BPS Guide to PHARMACOLOGY5892
KEGGcpd:C15182
dr:D06068
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Disease ProgressionFAERS: 310
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
US FAERS
2Renal Cell CarcinomaFAERS: 71US FAERS
3Blood creatinine increasedFAERS: 61SIDER
US FAERS
4ThrombocytopeniaFAERS: 55SIDER
US FAERS
5AstheniaFAERS: 52SIDER
US FAERS
6PneumoniaFAERS: 49SIDER
US FAERS
7FatigueFAERS: 42OFFSIDES
SIDER
US FAERS
8Metastatic Renal Cell CarcinomaFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
9NauseaFAERS: 38
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
10MalaiseFAERS: 36US FAERS
11General physical health deteriorationFAERS: 33US FAERS
12HypersensitivityFAERS: 32
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
13PneumonitisFAERS: 30US FAERS
14Back PainFAERS: 29SIDER
US FAERS
15StomatitisFAERS: 2916012795
20430774
CTD
SIDER
US FAERS
16Drug ineffectiveFAERS: 26
Canada Vigilance: 5
Canada Vigilance
US FAERS
17ErythemaFAERS: 26
Canada Vigilance: 1
17309148CTD
SIDER
Canada Vigilance
US FAERS
18FlushingFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
19EpistaxisFAERS: 24SIDER
US FAERS
20ExtravasationFAERS: 24SIDER
US FAERS
21VomitingFAERS: 24SIDER
US FAERS
22Alanine Aminotransferase IncreasedFAERS: 23SIDER
US FAERS
23Aspartate Aminotransferase IncreasedFAERS: 23SIDER
US FAERS
24Respiratory FailureFAERS: 23OFFSIDES
US FAERS
25PruritusFAERS: 20SIDER
US FAERS
26AscitesFAERS: 19US FAERS
27DehydrationFAERS: 19OFFSIDES
SIDER
US FAERS
28Infusion Site ExtravasationFAERS: 19US FAERS
29Blood alkaline phosphatase increasedFAERS: 16SIDER
US FAERS
30PancytopeniaFAERS: 16US FAERS
31Product use in unapproved indicationFAERS: 16US FAERS
32SepsisFAERS: 16SIDER
US FAERS
33Weight decreasedFAERS: 16SIDER
US FAERS
34Abdominal PainFAERS: 15SIDER
US FAERS
35Blood triglycerides increasedFAERS: 15SIDER
US FAERS
36Myocardial InfarctionFAERS: 15US FAERS
37Blood urea increasedFAERS: 14US FAERS
38Chest discomfortFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
39Blood lactate dehydrogenase increasedFAERS: 13US FAERS
40Diabetes MellitusFAERS: 13SIDER
US FAERS
41NeutropeniaFAERS: 1320430774CTD
SIDER
US FAERS
42PainFAERS: 12SIDER
US FAERS
43Pulmonary FibrosisFAERS: 12SIDER
US FAERS
44Intestinal PerforationFAERS: 11OFFSIDES
SIDER
US FAERS
45ProteinuriaFAERS: 1119212144CTD
US FAERS
46ArthralgiaFAERS: 10SIDER
US FAERS
47Blood cholesterol increasedFAERS: 10US FAERS
48Blood glucose increasedFAERS: 10SIDER
US FAERS
49Ejection Fraction DecreasedFAERS: 10US FAERS
50PeritonitisFAERS: 10OFFSIDES
US FAERS
51SomnolenceFAERS: 10SIDER
US FAERS
52Urinary tract infectionFAERS: 10SIDER
US FAERS
53AngioedemaFAERS: 9SIDER
US FAERS
54Chest PainFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
55HeadacheFAERS: 9SIDER
US FAERS
56HypotensionFAERS: 9US FAERS
57Injection site extravasationFAERS: 9US FAERS
58Mantle cell lymphomaFAERS: 9US FAERS
59Pneumocystis jiroveci pneumoniaFAERS: 9US FAERS
60White blood cell count decreasedFAERS: 9SIDER
US FAERS
61Angina PectorisFAERS: 8US FAERS
62Cerebral InfarctionFAERS: 8US FAERS
63Cerebrovascular accidentFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
64ChillsFAERS: 8SIDER
US FAERS
65ConjunctivitisFAERS: 8SIDER
US FAERS
66Dry skinFAERS: 8SIDER
US FAERS
67InfectionFAERS: 8SIDER
US FAERS
68Renal cancer metastaticFAERS: 8OFFSIDES
US FAERS
69Septic ShockFAERS: 8SIDER
US FAERS
70SyncopeFAERS: 8US FAERS
71TachycardiaFAERS: 8US FAERS
72ThrombosisFAERS: 8US FAERS
73UrticariaFAERS: 8US FAERS
74Drug toxicityFAERS: 7OFFSIDES
US FAERS
75DysgeusiaFAERS: 7SIDER
US FAERS
76Erythema MultiformeFAERS: 7SIDER
US FAERS
77Lip swellingFAERS: 7US FAERS
78Malignant neoplasm progressionFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
79Performance status decreasedFAERS: 7US FAERS
80SubileusFAERS: 7OFFSIDES
US FAERS
81Aphthous StomatitisFAERS: 6SIDER
US FAERS
82Atrial FibrillationFAERS: 6US FAERS
83HypothyroidismFAERS: 6US FAERS
84Infusion site swellingFAERS: 6US FAERS
85Metabolic acidosisFAERS: 6US FAERS
86MyalgiaFAERS: 6SIDER
US FAERS
87Nasal discomfortFAERS: 6US FAERS
88Pulmonary toxicityFAERS: 6US FAERS
89Rash erythematousFAERS: 6US FAERS
90Transaminases increasedFAERS: 6US FAERS
91Tumour haemorrhageFAERS: 6US FAERS
92Abdominal discomfortFAERS: 5US FAERS
93Acute respiratory failureFAERS: 5OFFSIDES
US FAERS
94Blood potassium decreasedFAERS: 5SIDER
US FAERS
95BradycardiaFAERS: 5US FAERS
96BronchitisFAERS: 5SIDER
US FAERS
97Depressed Level of ConsciousnessFAERS: 5US FAERS
98Dermatitis acneiformFAERS: 5US FAERS
99DizzinessFAERS: 5SIDER
US FAERS
100HepatotoxicityFAERS: 5US FAERS
101HypophagiaFAERS: 5US FAERS
102HypoxiaFAERS: 5OFFSIDES
US FAERS
103Joint swellingFAERS: 5US FAERS
104LeukopeniaFAERS: 5SIDER
US FAERS
105LymphocytosisFAERS: 5US FAERS
106Neutrophil count decreasedFAERS: 5US FAERS
107Oral painFAERS: 5SIDER
US FAERS
108Pericardial effusionFAERS: 5SIDER
US FAERS
109Pulmonary EmbolismFAERS: 5SIDER
US FAERS
110Respiratory distressFAERS: 5US FAERS
111Respiratory tract inflammationFAERS: 5US FAERS
112Skin lesionFAERS: 5US FAERS
113TremorFAERS: 5US FAERS
114Accidental overdoseFAERS: 4US FAERS
115AnorexiaFAERS: 420430774CTD
SIDER
US FAERS
116Blood creatine increasedFAERS: 4US FAERS
117Burning sensationFAERS: 4US FAERS
118Cardiac ArrestFAERS: 4US FAERS
119CholelithiasisFAERS: 4US FAERS
120DiscomfortFAERS: 4US FAERS
121DyspepsiaFAERS: 4US FAERS
122EpilepsyFAERS: 4US FAERS
123Feeling abnormalFAERS: 4US FAERS
124GastroenteritisFAERS: 4US FAERS
125Incorrect dose administeredFAERS: 4US FAERS
126MetastasisFAERS: 4US FAERS
127OnychoclasisFAERS: 4US FAERS
128PancreatitisFAERS: 4OFFSIDES
US FAERS
129Product use issueFAERS: 4US FAERS
130Stevens-Johnson SyndromeFAERS: 4
Canada Vigilance: 1
25811541CTD
SIDER
Canada Vigilance
US FAERS
131SwellingFAERS: 4SIDER
US FAERS
132Type III immune complex mediated reactionFAERS: 4OFFSIDES
US FAERS
133Wrong technique in drug usage processFAERS: 4US FAERS
134AcidosisFAERS: 3US FAERS
135Acute prerenal failureFAERS: 3US FAERS
136AlopeciaFAERS: 3US FAERS
137ArthritisFAERS: 3US FAERS
138Blood potassium increasedFAERS: 3US FAERS
139Bone painFAERS: 3US FAERS
140Cardiac enzymes increasedFAERS: 3US FAERS
141CholecystitisFAERS: 3OFFSIDES
US FAERS
142Circumstance or information capable of leading to medication errorFAERS: 3US FAERS
143ColitisFAERS: 3OFFSIDES
US FAERS
144CyanosisFAERS: 3OFFSIDES
US FAERS
145CystFAERS: 3OFFSIDES
US FAERS
146Cytolytic hepatitisFAERS: 3US FAERS
147DeafnessFAERS: 3US FAERS
148Deep Vein ThrombosisFAERS: 3SIDER
US FAERS
149Fibrin D dimer increasedFAERS: 3US FAERS
150Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
151Hepatic necrosisFAERS: 3US FAERS
152HepatitisFAERS: 3US FAERS
153HepatomegalyFAERS: 3US FAERS
154IleusFAERS: 3US FAERS
155Infusion site erythemaFAERS: 3US FAERS
156Intestinal ObstructionFAERS: 3US FAERS
157Large intestine perforationFAERS: 3US FAERS
158LeukocytosisFAERS: 3US FAERS
159Limb discomfortFAERS: 3US FAERS
160Lower respiratory tract infectionFAERS: 3US FAERS
161Lung consolidationFAERS: 3US FAERS
162Lymphangiosis carcinomatosaFAERS: 3US FAERS
163Lymphocyte count decreasedFAERS: 3SIDER
US FAERS
164Lymphocytic infiltrationFAERS: 3US FAERS
165Muscle tightnessFAERS: 3US FAERS
166Paraneoplastic Cerebellar DegenerationFAERS: 3OFFSIDES
US FAERS
167Peripheral swellingFAERS: 3US FAERS
168PolyuriaFAERS: 3US FAERS
169Pulmonary InfarctionFAERS: 3US FAERS
170PyopneumothoraxFAERS: 3US FAERS
171Silent myocardial infarctionFAERS: 3US FAERS
172Skin reactionFAERS: 3US FAERS
173Tooth ExtractionFAERS: 3US FAERS
174ToothacheFAERS: 3US FAERS
175UlcerFAERS: 3US FAERS
176Urinary IncontinenceFAERS: 3US FAERS
177Urinary RetentionFAERS: 3US FAERS
178VaricoceleFAERS: 3US FAERS
179VertigoFAERS: 3US FAERS
180jaundiceFAERS: 3US FAERS
181treatment failureFAERS: 3US FAERS
182AbasiaFAERS: 2OFFSIDES
US FAERS
183Abdominal adhesionsFAERS: 2OFFSIDES
US FAERS
184Accidental exposureFAERS: 2US FAERS
185AcneFAERS: 2SIDER
US FAERS
186Acute kidney injuryFAERS: 2US FAERS
187AgeusiaFAERS: 2SIDER
US FAERS
188AlkalosisFAERS: 2US FAERS
189Anal abscessFAERS: 2OFFSIDES
US FAERS
190Anaphylactic shockFAERS: 2SIDER
US FAERS
191Anaphylactoid ReactionFAERS: 2US FAERS
192AnxietyFAERS: 2SIDER
US FAERS
193AsthmaFAERS: 2US FAERS
194AtelectasisFAERS: 2US FAERS
195Atypical pneumoniaFAERS: 2US FAERS
196Blood cholesterol abnormalFAERS: 2OFFSIDES
US FAERS
197Blood electrolytes decreasedFAERS: 2US FAERS
198Blood sodium decreasedFAERS: 2US FAERS
199Blood urine presentFAERS: 2US FAERS
200CachexiaFAERS: 2US FAERS
201Cardiovascular insufficiencyFAERS: 2US FAERS
202Cell marker increasedFAERS: 2US FAERS
203CellulitisFAERS: 2SIDER
US FAERS
204Cerebral disorderFAERS: 2US FAERS
205Clostridium test positiveFAERS: 2US FAERS
206ConstipationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
207Creatinine renal clearance decreasedFAERS: 2US FAERS
208Cytokine Release SyndromeFAERS: 2US FAERS
209Decreased immune responsivenessFAERS: 2US FAERS
210DeliriumFAERS: 2US FAERS
211Diabetes mellitus inadequate controlFAERS: 2US FAERS
212Disease recurrenceFAERS: 2US FAERS
213DisorientationFAERS: 2US FAERS
214DiverticulitisFAERS: 2US FAERS
215DysuriaFAERS: 2SIDER
US FAERS
216Ear congestionFAERS: 2US FAERS
217EosinophiliaFAERS: 2US FAERS
218Escherichia test positiveFAERS: 2US FAERS
219Febrile NeutropeniaFAERS: 2SIDER
US FAERS
220Flank PainFAERS: 2US FAERS
221FolliculitisFAERS: 2SIDER
US FAERS
222Full blood count decreasedFAERS: 2US FAERS
223Gastrointestinal toxicityFAERS: 2US FAERS
224GoutFAERS: 2US FAERS
225HemiparesisFAERS: 2US FAERS
226Hepatic enzyme decreasedFAERS: 2US FAERS
227Hepatitis BFAERS: 2OFFSIDES
US FAERS
228HyperthyroidismFAERS: 2US FAERS
229HypertransaminasaemiaFAERS: 2US FAERS
230Iatrogenic infectionFAERS: 2US FAERS
231Increased upper airway secretionFAERS: 2US FAERS
232InflammationFAERS: 2US FAERS
233Infusion site painFAERS: 2US FAERS
234Infusion site warmthFAERS: 2US FAERS
235Injection site erythemaFAERS: 2US FAERS
236LaryngitisFAERS: 2SIDER
US FAERS
237LigamentitisFAERS: 2US FAERS
238LymphadenopathyFAERS: 2US FAERS
239LymphangitisFAERS: 2US FAERS
240Mastication disorderFAERS: 2OFFSIDES
US FAERS
241MastitisFAERS: 2US FAERS
242Medication ErrorFAERS: 2US FAERS
243Mental status changesFAERS: 2US FAERS
244NasopharyngitisFAERS: 2US FAERS
245Non-cardiac chest painFAERS: 2US FAERS
246Nonspecific reactionFAERS: 2US FAERS
247OnychomycosisFAERS: 2US FAERS
248OsteolysisFAERS: 2US FAERS
249OverdoseFAERS: 2US FAERS
250Productive CoughFAERS: 2US FAERS
251Pulmonary HypertensionFAERS: 2OFFSIDES
US FAERS
252Pulmonary congestionFAERS: 2US FAERS
253Pulmonary sepsisFAERS: 2US FAERS
254PurpuraFAERS: 2US FAERS
255Quality of life decreasedFAERS: 2US FAERS
256Renal tubular necrosisFAERS: 2US FAERS
257Respiratory arrestFAERS: 2US FAERS
258RhabdomyolysisFAERS: 2SIDER
US FAERS
259Right ventricular failureFAERS: 2US FAERS
260Skin UlcerFAERS: 2US FAERS
261Skin toxicityFAERS: 2US FAERS
262Squamous cell carcinomaFAERS: 2US FAERS
263Sudden deathFAERS: 2OFFSIDES
US FAERS
264Systemic Inflammatory Response SyndromeFAERS: 2US FAERS
265Therapeutic response unexpectedFAERS: 2US FAERS
266Thoracic vertebral fractureFAERS: 2US FAERS
267Throat irritationFAERS: 2US FAERS
268TinnitusFAERS: 2US FAERS
269TonsillitisFAERS: 2US FAERS
270Toxicity to various agentsFAERS: 2US FAERS
271TuberculosisFAERS: 2US FAERS
272Unresponsive to stimuliFAERS: 2US FAERS
273Visual ImpairmentFAERS: 2US FAERS
274Wound infection staphylococcalFAERS: 2US FAERS
275nervous system disorderFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
276Abdominal rigidityFAERS: 1US FAERS
277AgitationFAERS: 1US FAERS
278Alopecia totalisFAERS: 1US FAERS
279Altered state of consciousnessFAERS: 1US FAERS
280Ammonia increasedFAERS: 1US FAERS
281Amylase increasedFAERS: 1US FAERS
282Anal FistulaFAERS: 1OFFSIDES
US FAERS
283Anal inflammationFAERS: 1US FAERS
284Angle Closure GlaucomaFAERS: 1US FAERS
285Angular cheilitisFAERS: 1US FAERS
286AnuriaFAERS: 1OFFSIDES
US FAERS
287Aortic AneurysmFAERS: 1US FAERS
288ApathyFAERS: 1US FAERS
289Arterial fibrosisFAERS: 1US FAERS
290AsphyxiaFAERS: 1US FAERS
291Atrioventricular BlockFAERS: 1US FAERS
292Axonal neuropathyFAERS: 1US FAERS
293Basal cell carcinomaFAERS: 1US FAERS
294BedriddenFAERS: 1US FAERS
295BlindnessFAERS: 1US FAERS
296Blood albumin decreasedFAERS: 1US FAERS
297Blood creatine phosphokinase increasedFAERS: 1US FAERS
298Blood creatinine abnormalFAERS: 1US FAERS
299Blood electrolytes abnormalFAERS: 1US FAERS
300Blood magnesium decreasedFAERS: 1OFFSIDES
US FAERS
301Blood triglycerides abnormalFAERS: 1US FAERS
302Blood urea abnormalFAERS: 1US FAERS
303Bronchial ObstructionFAERS: 1US FAERS
304BronchiectasisFAERS: 1US FAERS
305Bronchopleural FistulaFAERS: 1US FAERS
306BronchopneumoniaFAERS: 1US FAERS
307BronchopneumopathyFAERS: 1US FAERS
308Bronchopulmonary AspergillosisFAERS: 1US FAERS
309BronchospasmFAERS: 1US FAERS
310Cancer PainFAERS: 1US FAERS
311Carbon dioxide decreasedFAERS: 1US FAERS
312CardiomegalyFAERS: 1US FAERS
313CardiotoxicityFAERS: 1OFFSIDES
US FAERS
314CataractFAERS: 1SIDER
US FAERS
315Catheter related infectionFAERS: 1US FAERS
316Central nervous system lesionFAERS: 1OFFSIDES
US FAERS
317CheilitisFAERS: 1US FAERS
318Chemical injuryFAERS: 1US FAERS
319ChokingFAERS: 1US FAERS
320CholestasisFAERS: 1US FAERS
321ChondrosisFAERS: 1US FAERS
322ChylothoraxFAERS: 1US FAERS
323ClubbingFAERS: 1US FAERS
324Coagulation test abnormalFAERS: 1US FAERS
325Colitis erosiveFAERS: 1OFFSIDES
US FAERS
326Coronary Artery DiseaseFAERS: 1US FAERS
327Culture urine positiveFAERS: 1US FAERS
328CytopeniaFAERS: 1US FAERS
329Device occlusionFAERS: 1US FAERS
330Device related infectionFAERS: 1US FAERS
331Diabetic FootFAERS: 1US FAERS
332Diffuse alveolar damageFAERS: 1US FAERS
333Drug dispensing errorFAERS: 1US FAERS
334Drug dose omissionFAERS: 1US FAERS
335Drug effective for unapproved indicationFAERS: 1US FAERS
336Drug label confusionFAERS: 1US FAERS
337DysarthriaFAERS: 1US FAERS
338DysphoniaFAERS: 1US FAERS
339Ear discomfortFAERS: 1US FAERS
340Ejection fraction abnormalFAERS: 1US FAERS
341Electrolyte imbalanceFAERS: 1US FAERS
342EmbolismFAERS: 1US FAERS
343EnteritisFAERS: 1US FAERS
344Enterococcus test positiveFAERS: 1US FAERS
345EnterocolitisFAERS: 1US FAERS
346EpiglottitisFAERS: 1US FAERS
347ErysipelasFAERS: 1US FAERS
348Exfoliative rashFAERS: 1SIDER
US FAERS
349Eye irritationFAERS: 1US FAERS
350Failure to ThriveFAERS: 1US FAERS
351Febrile bone marrow aplasiaFAERS: 1US FAERS
352Fluid overloadFAERS: 1US FAERS
353Gastric Antral Vascular EctasiaFAERS: 1US FAERS
354GastritisFAERS: 1SIDER
US FAERS
355Gastrointestinal erosionFAERS: 1US FAERS
356Gastrointestinal perforationFAERS: 1US FAERS
357Gastrointestinal wall thickeningFAERS: 1US FAERS
358Genital HerpesFAERS: 1US FAERS
359GlaucomaFAERS: 1US FAERS
360GlioblastomaFAERS: 121267448CTD
US FAERS
361HaematotoxicityFAERS: 1US FAERS
362HemiplegiaFAERS: 1US FAERS
363HydronephrosisFAERS: 1US FAERS
364HypocapniaFAERS: 1US FAERS
365HypokinesiaFAERS: 1US FAERS
366Impaired driving abilityFAERS: 1US FAERS
367Influenza A virus test positiveFAERS: 1US FAERS
368Infusion site reactionFAERS: 1US FAERS
369Injection Site ReactionFAERS: 1US FAERS
370Injection site warmthFAERS: 1US FAERS
371Intercepted medication errorFAERS: 1US FAERS
372Intestinal infarctionFAERS: 1US FAERS
373Joint Range of Motion DecreasedFAERS: 1US FAERS
374Joint abscessFAERS: 1US FAERS
375LeukoencephalopathyFAERS: 1US FAERS
376Lipase increasedFAERS: 1US FAERS
377Locked-In SyndromeFAERS: 1US FAERS
378Low density lipoprotein increasedFAERS: 1US FAERS
379Lymphocyte count increasedFAERS: 1US FAERS
380Malignant ascitesFAERS: 1US FAERS
381MalnutritionFAERS: 1SIDER
US FAERS
382Memory impairmentFAERS: 1US FAERS
383Meningitis herpesFAERS: 1US FAERS
384Mental impairmentFAERS: 1US FAERS
385Metastatic NeoplasmFAERS: 1US FAERS
386Mouth swellingFAERS: 1US FAERS
387Mucosal InfectionFAERS: 1US FAERS
388MumpsFAERS: 1US FAERS
389Muscle strainFAERS: 1US FAERS
390Musculoskeletal PainFAERS: 1US FAERS
391Musculoskeletal chest painFAERS: 1OFFSIDES
US FAERS
392Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
393Myoclonic EpilepsyFAERS: 1OFFSIDES
US FAERS
394MyopathyFAERS: 1US FAERS
395MyositisFAERS: 1US FAERS
396Neck PainFAERS: 1US FAERS
397Neisseria infectionFAERS: 1US FAERS
398NephritisFAERS: 1US FAERS
399NephrolithiasisFAERS: 1US FAERS
400NeuralgiaFAERS: 1US FAERS
401Neutropenic colitisFAERS: 1US FAERS
402Neutropenic sepsisFAERS: 1US FAERS
403Night sweatsFAERS: 1US FAERS
404No adverse eventFAERS: 1US FAERS
405Occupational exposure to productFAERS: 1US FAERS
406Ocular vascular disorderFAERS: 1US FAERS
407Oncologic complicationFAERS: 1US FAERS
408OnycholysisFAERS: 1US FAERS
409Oral candidiasisFAERS: 1US FAERS
410Oral mucosal eruptionFAERS: 1US FAERS
411Oral mucosal erythemaFAERS: 1US FAERS
412Oropharyngeal discomfortFAERS: 1US FAERS
413Oropharyngeal painFAERS: 1US FAERS
414Pain of skinFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
415PalpitationsFAERS: 1US FAERS
416PapuleFAERS: 1US FAERS
417Pathological fractureFAERS: 1US FAERS
418PeriodontitisFAERS: 1US FAERS
419Peripheral arterial occlusive diseaseFAERS: 1US FAERS
420Perirectal abscessFAERS: 1OFFSIDES
US FAERS
421PetechiaeFAERS: 1SIDER
US FAERS
422Pharmaceutical product complaintFAERS: 1US FAERS
423Pharyngeal lesionFAERS: 1US FAERS
424PharyngitisFAERS: 1SIDER
US FAERS
425Platelet aggregation abnormalFAERS: 1US FAERS
426Pneumatosis intestinalisFAERS: 1US FAERS
427PneumothoraxFAERS: 1US FAERS
428PolydipsiaFAERS: 1US FAERS
429PoriomaniaFAERS: 1US FAERS
430Post-anoxic myoclonusFAERS: 1US FAERS
431Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
432Pre-existing condition improvedFAERS: 1US FAERS
433Product dispensing errorFAERS: 1US FAERS
434Product packaging issueFAERS: 1US FAERS
435Product packaging quantity issueFAERS: 1US FAERS
436Product preparation issueFAERS: 1US FAERS
437Product use complaintFAERS: 1US FAERS
438Protein total decreasedFAERS: 1OFFSIDES
US FAERS
439Protein total increasedFAERS: 1US FAERS
440Pseudomonal sepsisFAERS: 1US FAERS
441Pulmonary thrombosisFAERS: 1US FAERS
442PurulenceFAERS: 1OFFSIDES
US FAERS
443PyelonephritisFAERS: 1US FAERS
444Respiratory tract congestionFAERS: 1US FAERS
445Rotator cuff syndromeFAERS: 1US FAERS
446SarcoidosisFAERS: 1US FAERS
447Secondary hypertensionFAERS: 1US FAERS
448Serratia test positiveFAERS: 1US FAERS
449ShockFAERS: 1US FAERS
450Sinus headacheFAERS: 1US FAERS
451SinusitisFAERS: 1OFFSIDES
SIDER
US FAERS
452Skin necrosisFAERS: 1US FAERS
453Skin tightnessFAERS: 1US FAERS
454Spinal column injuryFAERS: 1US FAERS
455Splenic RuptureFAERS: 1US FAERS
456SplenomegalyFAERS: 1US FAERS
457Sputum culture positiveFAERS: 1US FAERS
458SunburnFAERS: 1US FAERS
459SuperinfectionFAERS: 1US FAERS
460Supraventricular tachycardiaFAERS: 1US FAERS
461Systemic mycosisFAERS: 1US FAERS
462Transfusion ReactionFAERS: 1US FAERS
463Troponin increasedFAERS: 1OFFSIDES
US FAERS
464Urinary tract obstructionFAERS: 1US FAERS
465Uterine CancerFAERS: 1US FAERS
466Vein collapseFAERS: 1US FAERS
467Venous InsufficiencyFAERS: 1US FAERS
468Venous thrombosis limbFAERS: 1US FAERS
469Ventricular hypokinesiaFAERS: 1US FAERS
470Wound ComplicationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
471X-ray abnormalFAERS: 1US FAERS
472pseudomembranous colitisFAERS: 1US FAERS
473Abnormal visionOFFSIDES
474AbscessSIDER
475Activities of daily living impairedOFFSIDES
476Adrenal gland cancer metastaticOFFSIDES
477AlveolitisSIDER
478Anal FissureOFFSIDES
479Anal candidiasisSIDER
480AngerOFFSIDES
481AnhedoniaOFFSIDES
482AtaxiaOFFSIDES
483Atrial thrombosisOFFSIDES
484Bacterial test positiveOFFSIDES
485Base excess decreasedOFFSIDES
486Bladder painSIDER
487Bladder spasmOFFSIDES
488Blood GlucoseOFFSIDES
489Blood and lymphatic system disordersSIDER
490Blood creatine phosphokinase MB increasedOFFSIDES
491Blood phosphorus decreasedSIDER
492Blood sodiumOFFSIDES
493Blood testosterone decreasedOFFSIDES
494Blood triglyceridesOFFSIDES
495Bone density decreasedOFFSIDES
496Brain DeathOFFSIDES
497Bulbar palsyOFFSIDES
498Cardiac TamponadeOFFSIDES
499Cardiac function test abnormalOFFSIDES
500Cerebrospinal fistulaOFFSIDES
501Cervicobrachial syndromeSIDER
502Creatinine increasedSIDER
503CystitisSIDER
504DermatitisSIDER
505DiabetesOFFSIDES
506Diarrhea20430774CTD
507Drug withdrawal headacheOFFSIDES
508Duodenal perforationSIDER
509Early satietyOFFSIDES
510EcchymosisSIDER
511EczemaSIDER
512Electrocardiogram ST-T changeOFFSIDES
513EmpyemaOFFSIDES
514Enterococcal sepsisOFFSIDES
515Eosinophilic PneumoniaSIDER
516Escherichia sepsisOFFSIDES
517Escherichia urinary tract infectionOFFSIDES
518Exanthema20430774CTD
519Fever20430774CTD
520Fungal test positiveOFFSIDES
521Gastrointestinal PainSIDER
522General physical conditionOFFSIDES
523GingivitisSIDER
524GlobulinuriaOFFSIDES
525GlossitisSIDER
526Glucose increasedSIDER
527GranulocytosisOFFSIDES
528Herpes simplex serology positiveOFFSIDES
529HypercapniaOFFSIDES
530Hyperglycemia20430774CTD
531Hypertriglyceridemia20430774CTD
532Hypophosphatemia20430774CTD
533ImmunosuppressionOFFSIDES
534InfestationSIDER
535InfluenzaSIDER
536Inspiratory capacity decreasedOFFSIDES
537Intervertebral disc disorderOFFSIDES
538Intestinal ulcer perforationOFFSIDES
539Kidney FailureOFFSIDES
540Lacrimal structural disorderSIDER
541Left atrial dilatationOFFSIDES
542Liver AbscessOFFSIDES
543Loose toothOFFSIDES
544Loss of proprioceptionOFFSIDES
545Lung AbscessOFFSIDES
546Lymphopenia16012795CTD
SIDER
547Mesothelioma21358348CTD
548Necrosis20828385CTD
549Neoplasms, Experimental

View details

CTD
550Neoplasms17309148CTD
551NephrectomyOFFSIDES
552Nephrotic SyndromeOFFSIDES
553OsteomyelitisOFFSIDES
554Perineal fistulaOFFSIDES
555PeriostitisOFFSIDES
556PeriproctitisOFFSIDES
557Phosphorus lowSIDER
558Potassium lowSIDER
559ProctitisOFFSIDES
560Prostatic Neoplasms19706800
22532600
CTD
561PrurigoSIDER
562Reflex Sympathetic DystrophySIDER
563RhinitisSIDER
564Soft tissue necrosisOFFSIDES
565ThrombophlebitisSIDER
566Troponin I increasedOFFSIDES
567Tuberous Sclerosis16845661CTD
568Venous ThromboembolismSIDER
569Venous ThrombosisSIDER
570VertebroplastyOFFSIDES
571Vesiculobullous rashSIDER
572Wound InfectionSIDER
573furuncleOFFSIDES
574melanoma17508024CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.